EDGAR Filing Documents for 0001104659-16-156253

Form 8-K - Current report:

SEC Accession No. 0001104659-16-156253

Filing Date

2016-11-10

Accepted

2016-11-10 16:30:55

Documents

Period of Report

2016-11-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-21456_18k.htm	8-K	31181
2	EX-4.1	a16-21456_1ex4d1.htm	EX-4.1	96946
3	EX-4.2	a16-21456_1ex4d2.htm	EX-4.2	97466
4	EX-10.1	a16-21456_1ex10d1.htm	EX-10.1	365649
5	EX-99.1	a16-21456_1ex99d1.htm	EX-99.1	12791
6	GRAPHIC	g214561mmi001.jpg	GRAPHIC	2726
	Complete submission text file	0001104659-16-156253.txt		609254

Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004

Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072

Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)